Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cytrellis Biosystems, Inc. logo — Advancing aesthetics with the first-of-its-kind ellacor® Sys...

Cytrellis Biosystems, Inc.

Advancing aesthetics with the first-of-its-kind ellacor® System with Micro-Coring® Technology.

Founded 2012 United States Woburn, United States 59 employees Series C Total: $86.09M Biotechnology, Health Care

General Information

Company Name Cytrellis Biosystems, Inc.
Founded Year 2012
Location United States Woburn, United States +1
Employees 59
Industries Biotechnology, Health Care
Funding Stage Series C
Social

Get notified when Cytrellis Biosystems, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cytrellis Biosystems, Inc.

Cytrellis Biosystems, Inc. is a pioneering biotechnology company established in 2012 with a focus on advancing aesthetics through their innovative ellacor® System with Micro-Coring® Technology. This medical technology company is dedicated to enhancing the quality of life for patients by emphasizing safety and efficacy. Their flagship product, the ellacor® System, is designed for treating moderate to severe wrinkles in the mid to lower face for adults aged 22 years or older with Fitzpatrick skin types I-IV. It provides aesthetic practitioners with an unprecedented ability to improve age-related changes in the skin, thus contributing to the restoration of youthful beauty. Cytrellis Biosystems, Inc. recently secured a significant $50.00M Series C investment on 04 January 2021, attracting prominent investors including Arch Venture Partners, D1 Capital Partners, Sands Capital Ventures, and PFM Health Sciences. This investment is a testament to their strong market potential and the confidence that leading venture capital firms have in the company's vision and technologies. With their emphasis on safety and efficacy, and the notable support from major investors, Cytrellis Biosystems, Inc. is poised to make a significant impact in the health care and biotechnology industries.

Taxonomy: aesthetic devices, dermatology, scar reduction, anti-aging, Micro-Coring® Technology, clinical stage, sagging skin, Fitzpatrick skin types, Boston-based, youthful beauty, wrinkle treatment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 4
Investor Investor Investor Investor
04 Jan 2021
Series B •••••• 4
Investor Investor Investor
•••• •••• 		05 Jun 2018
Series A •••••• 1
Investor
20 Feb 2015
Debt Financing •••••• - 01 Dec 2012

Cytrellis Biosystems, Inc. Alternatives & Competitors

Cytrellis Biosystems, Inc. vs
AVAVA
AVAVA United States

Boundless Energy. Fearless Vision.

64 employees
Cytrellis Biosystems, Inc. vs
SKIN Clinics
SKIN Clinics Canada

SKIN Clinics is proud to be a dermatologist run cosmetic clinic in Western Manitoba, Saskatchewan, a...

50 employees
Health Care
Compare Cytrellis Biosystems, Inc. vs SKIN Clinics
Cytrellis Biosystems, Inc. vs
SkinSmart Dermatology
SkinSmart Dermatology United States

Providing the Sun Coast with the Highest-Quality Medical, Surgical, and Cosmetic Dermatology Since 2...

29 employees
Health Care, Wellness Beauty
Compare Cytrellis Biosystems, Inc. vs SkinSmart Dermatology
Also compare with: Cytrellis Biosystems, Inc. vs Advanced Skin & Body Solutions Advanced Skin & Body Solutions

FAQ About Cytrellis Biosystems, Inc.

Advancing aesthetics with the first-of-its-kind ellacor® System with Micro-Coring® Technology.
Cytrellis Biosystems, Inc. was founded in 2012.
Cytrellis Biosystems, Inc. is headquartered in Woburn, United States.
Cytrellis Biosystems, Inc. operates in the following industries: Biotechnology, Health Care.
Cytrellis Biosystems, Inc. has approximately 59 employees.
Cytrellis Biosystems, Inc. has completed 4 funding rounds, raising a total of $86.09M. The latest funding stage is Series C.
Top alternatives and competitors to Cytrellis Biosystems, Inc. include AVAVA, SKIN Clinics, SkinSmart Dermatology, SKN BAR RX, Cortex Technology ApS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cytrellis Biosystems, Inc. and AVAVA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cytrellis Biosystems, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy